Valuation: Ipca Laboratories Limited

Market Cap 440B 4.6B 3.97B 3.73B 3.4B 6.39B 6.49B 43.76B 17.11B 220B 17.28B 16.9B 732B P/E 2027 *
29.1x
P/E 2028 * 26.5x
Enterprise Value 428B 4.48B 3.87B 3.63B 3.3B 6.21B 6.32B 42.58B 16.65B 214B 16.81B 16.45B 712B EV / Sales 2027 *
3.89x
EV / Sales 2028 * 3.46x
Free-Float
54.94%
Yield 2027 *
0.33%
Yield 2028 * 0.36%
1 day-3.46%
1 week-0.09%
Current month-0.78%
1 month-5.77%
3 months+9.49%
6 months+16.75%
Current year+22.22%
1 week 1,674.4
Extreme 1674.4
1,905
1 month 1,674.4
Extreme 1674.4
1,944.9
Current year 1,391.8
Extreme 1391.8
1,944.9
1 year 1,251.6
Extreme 1251.6
1,944.9
3 years 856.8
Extreme 856.8
1,944.9
5 years 669.8
Extreme 669.8
1,944.9
10 years 200
Extreme 200
1,944.9
Manager TitleAgeSince
Chief Executive Officer 53 31/03/2023
Chief Executive Officer 70 31/03/2023
Chief Tech/Sci/R&D Officer 52 15/10/2023
Director TitleAgeSince
Chairman 79 04/07/2012
Director/Board Member 53 10/11/2008
Director/Board Member 70 31/07/1994
Date Insider Type Main position Quantity % Market Cap.
19/12/24 Sell 4,000,000 1.5766%
Change 5-day change 1-year change 3-year change Capi.($)
-3.46%-0.09%+26.96%+96.08% 4.78B
-2.25%-0.47%+72.43%+119.36% 1,078B
-0.66%+0.43%+49.01%+50.11% 632B
-0.54%+1.39%+21.88%+63.83% 443B
-1.99%-3.32%+41.98%+34.08% 356B
-1.05%-2.81%+24.22%+34.67% 289B
-2.12%-3.67%-1.09%+3.11% 245B
-0.63%+1.04%+43.03%+59.10% 226B
-1.19%-3.41%-9.18%-52.41% 204B
+0.16%+3.87%+16.25%+73.27% 171B
Average -0.94%+0.75%+28.55%+48.12% 364.85B
Weighted average by Cap. -0.09%+0.31%+41.43%+62.27%

Financials

2027 *2028 *
Net sales 110B 1.15B 993M 933M 849M 1.6B 1.62B 10.93B 4.27B 55.05B 4.32B 4.22B 183B 120B 1.26B 1.09B 1.02B 928M 1.74B 1.77B 11.95B 4.67B 60.18B 4.72B 4.62B 200B
Net income 15.49B 162M 140M 131M 120M 225M 229M 1.54B 602M 7.76B 608M 595M 25.78B 17.03B 178M 154M 145M 131M 247M 251M 1.69B 662M 8.53B 669M 654M 28.33B
Net Debt -11.82B -124M -107M -100M -91.27M -172M -174M -1.18B -460M -5.92B -464M -454M -19.68B -23.66B -247M -214M -201M -183M -343M -349M -2.35B -920M -11.85B -929M -909M -39.37B
Logo Ipca Laboratories Limited
Ipca Laboratories Limited is an India-based integrated pharmaceutical company. The Company is engaged in manufacturing and marketing over 350 formulations and approximately 80 active pharmaceutical ingredients (APIs) covering various therapeutic segments. It offers APIs, such as Atenolol, Chloroquine Phosphate, Chlorthalidone, Furosemide, Hydroxychloroquine sulfate, Losartan, Metoprolol Succinate, Metoprolol Tartrate, Pyrantel Salts and Propranolol. The Company offers brands, such as Zerodol, Lariago, HCQS, Perinorm, Rapither AB, Tenoric, Lumerax, Etova, Fexova, Malirid, Allsuth, Alwiz, AZR 50mg, Bacilon, Cinkona, Clarbact, Glyree MV, Halotop, Luliz, Ozepam, Pacimol, Pari, Xtor-F, Zabpro, Zilast, Ramcor, Sove, Venpower and Folitrax. The Company’s products are sold in over 100 countries across the globe. The Company has 18 manufacturing units in India manufacturing APIs and formulations. Its subsidiaries include Ipca Pharmaceuticals, Inc. and Ipca Pharma Nigeria Ltd.
Employees
17,210
Date Price Change Volume
14/08/26 ₹1,734.20 -3.46% 390,591
13/08/26 ₹1,796.30 +1.68% 1,835,473
12/08/26 ₹1,766.60 +1.04% 149,151
11/08/26 ₹1,748.40 +3.71% 233,132
10/08/26 ₹1,685.80 -2.88% 239,283
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
1,734.20INR
Average target price
1,733.50INR
Spread / Average Target
-0.04%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IPCALAB Stock